Abstract
The term “catecholamine” refers to a series of organic compounds which have a benzene nucleus with two adjacent hydroxyl groups (the catechol nucleus) and amine group. Thus dopamine (dihydroxyphenylethylamine), noradrenaline (β-hydroxy dihydroxyphenylethylamine), and adrenaline (N-methyl-β-hydroxy dihydroxyphenylethylamine) and certain of their metabolites are catecholamines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alousi, A., and Weiner, N., 1966, Proc. Natl. Acad. Sci. (U.S.) 56: 1491.
Anden, N. E., Corrodi, H., Fuze, K., Hökfelt, T., Rydin, C., and Svensson, T., 1970, Life-Sci. 9: 513–523.
Armstrong, M. D., McMillan, A., and Shaw, K. N. F., 1957, Biochim. Biophys. Acta 25: 422.
Assicot, M., and Bohuon, C., 1971, Biochimie 53: 871.
Aunis, D., Miras-Portugal, M. T., and Mandel, P., 1973a, Biochim. Biophys. Acta 327: 313.
Aunis, D., Miras-Portugal, M. T., and Mandel, P., 1973b, Biochem. Pharmacol. 22: 2581.
Aunis, D., Miras-Portugal, M. T., and Mandel, P., 1974, Biochim. Biophys. Acta 365: 259.
Aunis, D., Allard, D., Miras-Portugal, M. T., and Mandel, P., 1975, Biochim. Biophys. Acta, (in press).
Axelrod, J., 1962a, J. Biol. Chem. 237: 1657–1660.
Axelrod, J., 1962b, J. Pharmacol. Exptl. Therap. 138: 28.
Axelrod, J., 1963, Science 140: 499.
Axelrod, J., and Tomchick, R. 1958, J. Biol. Chem. 233: 702.
Axelrod, J. and Vessell, E. S., 1970, Mol. Pharmacol. 6: 78.
Axelrod, J., and Weinshilboum, R., 1972, New Engl. J. Med. 287: 237.
Axelrod, J., Albers, R. W., and Clemente, C. D., 1959a, J. Neurochem. 5: 68.
Axelrod, J., Hertting, G., and Patrick, R. W., 1961, J. Pharmacol. Exptl. Therap. 134: 325.
Bagchi, S. P., and McGeer, P. L., 1964, Life Sci. 3: 1195.
Barbeau, A., 1961, Proc. 7th Int. Congr. Neurol., vol. 2, p. 925, Societa Grafica Romana, Rome.
Barbeau, A., 1974, Ann. Rev. Pharmacol. 14: 91.
Bartholini, G., and Pletscher, A., 1968, J. Pharmacol. Exptl. Therap. 161: 14.
Bartholini, G., Haefely, W., Jalfre, M., Keller, H. H., and Pletscher, A. 1972, Brit. J. Pharmacol. 46: 736.
Belleau, B., and Burba, J. 1961, Biochim. Biophys. Acta 54: 195.
Bender, D. A., and Coulson, W. F., 1972, J. Neurochem. 19: 2801.
Benfey, B. G., Ledoux, G., and Melville, K. I., 1959, Brit. J. Pharmacol. 14: 142.
Bertler, A., 1961, Acta Physiol. Scand. 51: 97–107.
Bertler, A., and Rosengren, E., 1959a, Acta Physiol. Scand. 47: 350.
Bertler, A., and Rosengren, E., 1959b, Acta Physiol. Scand. 47: 362.
Birkmayer, W., and Hornykiewicz, O., 1961, Wien. Klin. Wochschr. 73: 787.
Bisby, M. A., Fillenz, M., and Smith, A. D., 1973, J. Neurochem. 20: 245.
Blaschko, H., 1939, J. Physiol. (Lond.) 96: 50 p.
Blaschko, H., 1952 Pharmacol. Rev. 63: 415.
Blaschko, H., Richter, D., and Schlossmann, H., 1937a, J. Physiol. (Lond.) 90: 1
Blaschko, H., Richter, D., and Schlossmann, H., 1937b, Biochem. J. 31: 2187.
Bloom, F. E., 1972, Catecholamines, in Handbook of Experimental Pharmacology, Vol. 33, H. Blaschko, and E. Muscholl, eds., pp. 46–78, Springer-Verlag, Heidelberg.
Bogdanski, D. F., Weissbach, H., and Udenfriend, S., 1957, J. Neurochem. 1: 272.
Bohuon, C., and Assicot, M., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 107–112, Pergamon Press, Oxford.
Brandau, K., and Axelrod, J., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 129–131, Pergamon Press, Oxford.
Brown, G. L., 1960, In: Adrenergic Mechanisms, pp. 116–124, Ciba, Churchill, London. Brown, G. L., 1965, Proc. Roy. Soc. London Ser. B. 162:1.
Brown, G. L., and Gillespie, J. S., 1957, J. Physiol. (London) 138: 81.
Burack, W. R., and Draskoczy, P. R. 1964, J. Pharmacol. Exptl. Therap. 144: 66.
Burn, J. H., and Rand, M. J., 1958, J. Physiol. (London) 144: 314.
Cannon, W. B., and Uridil, J. E., 1921, Am. J. Physiol. 58: 353.
Carlsson, A., 1972, Acta Neurol. Scand. Suppl. 51: 11.
Carlsson, A., Rosengren, E., Bertler, A., and Nilsson, J. 1957, In: Psychotropic Drugs (S. Garattini and V. Ghetti eds.), pp. 363–372, Elsevier, Amsterdam.
Carlsson, A., Lindqvist, M., Magnusson, T., and Waldeck, B., 1958, Science 127: 417.
Carlsson, A., Falck, B., and Hillarp, N.-A., 1962a, Acta Physiol. Scand. Suppl. 196: 28.
Cattabeni, F., Koslow, S. H., and Costa, E. 1972, Science 178: 166.
Celander, O., 1954, Acta Physiol. Scand. Suppl. 116: 128.
Chidsey, C. A., and Harrison, D. C., 1963, J. Pharmacol. Exptl. Therap. 140: 217.
Christenson, J. G., Dairman, W. D., and Udenfriend, S., 1970, Arch. Biochem. Biophys. 141: 356.
Chrusciel, T. L., 1960, In: Adrenergic Mechanisms (J. R. Vane, G. E. W. Wolstenholme, and M. O’Connor, eds.), pp. 539, Churchill, London.
Chubb, I. W., Preston, B. N., and Austin, L., 1969, Biochem. J. 111: 243.
Ciaranello, R. D., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 101–105, Pergamon Press, Oxford.
Ciaranello, R. D., Jacobowitz, D., and Axelrod, J. 1973, J. Neurochem. 20: 799.
Costa, E., Green, A. R., Koslow, S. H., Lefevre, H. J. Revuelta, A. V., and Wang, C. 1972, Pharmacol. Rev. 24: 167.
Costa, E., and Neff, N. H. 1966, In: Biochemistry and Pharmacology of the Basal Ganglia (E. Costa, L. T. Côte, and M. D. Yahr, eds.), pp. 141–155, Raven Press, New York.
Cotzias, G. C., Papavasiliou, P. S., Ginos, J., Steck, A., and Dliby, S., 1971, Ann. Rev. Med. 22: 305.
Coyle, J. T., 1972, Biochem. Pharmacol. 21: 1935.
Creveling, C. R., Dalgard, N., Shimizu, H., and Daly, J. W., 1970, Mol. Pharmacol. 6: 691.
Creveling, C. R., Morris, N., Shimizu, H., Ong, H. H., and Daly, J. W., 1972, Mol. Pharmacol. 8: 398.
Crout, J. R., 1964, Proc. Soc. Expt. Biol. Med. 108: 482.
Cuello, A. C., Hiley, R., and Iversen, L. L., 1973, J. Neurochem. 21: 1337.
Dahlström, A., 1965, J. Anat. (London) 99: 677.
Dahlström, A., and Fuxe, K., 1965, Acta Physiol. Scand. Suppl. 247: 36.
Dahlström, A., Fuxe, K., and Hillarp, N.-A., 1965, Acta Pharmacol. Toxicol. 22: 277.
Dairman, W., Christenson, J. G., and Udenfriend, S., 1971, Proc. Natl. Acad. Sci. (U.S.) 68: 2117.
Dairman, W., Christenson, J. G., and Udenfriend, S., 1972, Pharmacol. Rev. 24: 269.
Dairman, W., Christenson, J. G., and Udenfriend, S., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 61–67, Pergamon Press, Oxford.
Daly, J. W., Axelrod, J., and Witkop, B., 1960, J. Biol. Chem. 235: 1155.
Demis, D. J., Blaschko, H., and Welch, A. D., 1955, J. Pharmacol. Exptl. Therap. 113: 14.
Dengler, H. J., Michaelson, I. A., Spiegel, H. E., and Titus, E. O. 1962, Intern. J. Pharmacol. 1: 23.
Dengler, H. J., Spiegel, H. E., and Titus, E. O. 1961, Science 133: 1072.
De Potter, W. P., Smith, D. A., and De Schaepdryver, A. F., 1970, Tissue and Cell 2: 529.
De Robertis, E., and Bennett, H. S., 1954, Federation Proc. 13: 35.
De Robertis, E., and Pellegrino De Iraldi, A., 1961a, Experientia 17: 122.
De Robertis, E., and Pellegrino De Iraldi, A., 1961b, J. Biophys. Biochem. Cytol. 10: 361.
De Schaepdryver, A. F., and Kirshner, N., 1961, Arch. Intern. Pharmacodyn. Therap. 131: 433.
Diliberto, E. J., Jr., and DiStefano, V., 1969, Anal. Biochem. 32: 281.
Douglas, W. W., and Rubin, R. P. 1963, J. Physiol. (London) 167: 288.
Duncan, R. J. S., and Tipton, K. F., 1971, European J. Biochem. 22: 257.
Eagles, P. A. M., and Iqbal, M., 1974, Brain Res. 80: 177.
Eccles, J. C., 1964, The Physiology of Synapses Springer-Verlag, Berlin.
Ehringer, H., and Hornykiewicz, O., 1960, Wien. Klin. Wochschr. 38: 1236.
Eliasson, R., von Euler, U. S., and Stjärne, L., 1955, Acta Physiol. Scand. Suppl. 118: 69.
Eränko, O., 1952, Acta Anat. (Basel) 16 (Suppl. 16): 60.
Ericsson, A. D., 1971, J. Neurol. Sci., 14: L93.
Erwin, V. G., and Deitrich, R. A., 1966, J. Biol. Chem. 241: 3533.
Erwin, V. G., Heston, W. D., and Tabakoff, B., 1972, J. Neurochem. 19: 2269.
Euler, U. S. von, 1946, Acta Physiol. Scand. 12: 73.
Euler, U. S. von, 1956, Noradrenaline American Lecture Series (Physiology), (R. F. Pitts, ed.), Charles C. Thomas, Springfield.
Euler, U. S. von, and Lishajko, F., 1963, Acta Physiol. Scand. 57: 468.
Euler, U. S. von, Franksson, C., and Hellström J., 1954, Acta Physiol. Scand. 31: 1.
Euler, U. S. von, Björkman, S., and Orwen, I., 1955, Acta Physiol. Scand. Suppl. 118: 10.
Falck, B., 1962, Acta Physiol. Scand. Suppl. 197: 26.
Falck, B., and Hillarp, N.-A., 1959, Acta Anat. 38: 277.
Falck, B., and Torp, A., 1961, Med. Exp. 5: 428.
Falck, B., Hillarp, N.-A., Thieme G., and Torp, A., 1962, J. Histochem. Cytochem. 10: 348.
Foldes, A., and Meek, J. L., 1973, Federation Proc. 32: 797.
Friedhoff, A. J., and Van Winkle, E., 1962, Nature 194: 897.
Friedhoff, A. J., Schweitzer, J. W., and Miller, J., 1972a, Res. Commun. Pharmacol. Pharm. Pathol. 3: 293.
Friedhoff, A. J., Schweitzer, J. W., and Miller, J., 1972b, Nature 237: 454.
Fuller, R. W., and Hunt, J. M., 1967, Life Sci. 6: 1107.
Fuller, R. W., Warren, B. J., and Molloy, B. B. 1970, Biochim. Biophys. Acta 222: 210.
Fuxe, K. 1966, Pharmacol. Rev. 18: 641.
Fuxe, K., and Ungerstedt, U., 1970, Symposium on Amphetamine and Related Compounds (E. Costa and S. Garattini, eds.), pp. 257–288, Raven Press, New York.
Fuxe, K., Goldstein, M., Hökfelt, T., Freedman, L., and Anagnoste, B., 1971, Acta Pharmacol. Toxicol. 29 (Suppl. 4): 15.
Fuxe, K., Goldstein, M., Hökfelt, T., Joh, T. H., Freedman, L. S., and Anagnoste, B., 1972, Federation Proc. 31: 544.
Gabay, S., and Valcourt, A. J., 1968, Biochim. Biophys. Acta 159: 440.
Gaddum, J. H., and Kwiatkowski, H., 1939, J. Physiol. (London) 96: 385.
Geffen, L., 1974, Life Sci. 14: 1593.
Geffen, L. B., and Ostberg, A., 1969, J. Physiol. (London) 204: 583.
Geffen, L. B., and Rush, R. A. 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 483–489, Pergamon Press, Oxford.
Gillespie, J. S., and Kirpekar, S. M., 1965, J. Physiol. (London) 178: 44 p.
Glowinski, J., and Axelrod, J., 1966, Pharmacol. Rev. 18: 775.
Glowinski, J., and Iversen, L. L. 1966, J. Neurochem. 13: 655.
Glowinski, J., Kopin, I. J., and Axelrod, J.. 1965, J. Neurochem. 12: 25.
Goldstein, M., 1966, Pharmacol. Rev. 18: 77.
Goldstein, M., 1972, In: Research Methods in Neurochemistry (N. Marks and R. Rodnight, eds.), pp. 317–340, Plenum Press, New York.
Goldstein, M., and Gerber, H., 1963, Life Sci. 2: 97.
Goldstein, M., Anagnoste, B., Yamamoto, H., and Fetch, W. C., 1970, J. Pharmacol. Exptl. Therap. 171: 196.
Goldstein, M., Ohi, Y., and Backstrom, T., 1970a, J. Pharmacol. Exptl. Therap. 174: 77.
Goldstein, M., Freedman, L. S., and Backstrom, T., 1970b, J. Pharm. Pharmacol. 22: 715.
Goldstein, M., Anagnoste, B., Freedman, L. S., Roffman, M., Ebstein, R. P., Park, D. H., Fuxe, K., and Hökfelt, T., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 69–78, Pergamon Press, Oxford.
Goldstein, M., and Weiss, Z. 1965, Life Sci. 4: 261.
Gray, E. G., and Whittaker, V. P., 1962, J. Anat. 96: 79.
Haefely, W., Hiirlimann, A., and Thoenen, H., 1965, J. Physiol. (London) 181: 48.
Hagen, P., 1956, J. Pharmacol. Exptl. Therap. 116: 26.
Hall, D. W. R., Logan, B. W., and Parsons, G. H., 1969, Biochem. Pharmacol. 18: 1447
Hamberger, B., Malmfors, T., Norberg, K. A., and Sachs, C., 1964, Biochem. Pharmacol. 13: 841.
Hare, M. L. C., 1928, Biochem. J. 22: 968.
Harris, J. E., and Roth, R. H., 1971, Mol. Pharmacol. 7: 593.
Hertting, G., 1964, Biochem. Pharmacol. 13: 1119.
Hertting, G., and Axelrod, J., 1961, Nature 192: 172.
Hertting, G., Axelrod, J., Kopin, I. J., and Whitby, L. G., 1961, Nature 189: 66.
Herrting, G., Potter, L. T., and Axelrod, J. 1962, J. Pharmacol. Exptl. Therap. 136: 289.
Hess, S. M., Connamacher, R. H., Ozaki, M., and Udenfriend, S., 1961, J. Pharmacol. Exptl. Therap. 134: 129.
Idaka, H., 1973, In: Frontiers in Catecholamine Research, (E. Usdin and S. Snyder, eds.,), pp. 87–90, Pergamon Press, Oxford.
Hillarp, N.-A., and Hökfelt, T., 1953, Acta Physiol. Scand. 30: 55.
Himwich, H. E., and Alpers, H. S., 1970, Ann. Rev. Pharmacol. 10: 213.
Hökfelt, T., 1968, Z. Zellforsch. 91: 1.
Hökfelt, T., 1969, Acta Physiol. Scand. 76: 427.
Hökfelt, T., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 439–446, Pergamon Press, Oxford.
Holtz, P., 1950, Acta Physiol. Scand. 20: 354.
Holtz, P., Heise, R., and Ludtke, K., 1938, Arch. Exptl. Pathol. Pharmakol. 191: 87.
Holzbauer, M. and Vogt, M., 1956, J. Neurochem. 1: 8.
Houslay, M. D., and Tipton, K. E., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 147–149, Pergamon Press, Oxford.
Ikeda, M., Fahien, L. A., and Udenfriend, S., 1966, J. Biol. Chem. 241: 4452.
Ikeda, M., Levitt, M., and Udenfriend, S., 1965, Biochem. Biophys. Res. Commun. 18: 482.
Iversen, L. L., 1963, Brit. J. Pharmacol. Chemother. 21: 523.
Iversen, L. L., 1965, Brit. J. Pharmacol. Chemother. 25: 18.
Iversen, L. L., and Glowinski, J., 1966, J. Neurochem. 13: 671.
Iversen, L. L., Glowinski, J., and Axelrod, J., 1966, J. Pharmacol. Exptl. Therap. 151: 273.
Iversen, L. L., and Whitby, L. G., 1962, Brit. J. Pharmacol. Chemother. 19: 355.
Joh, T. H., and Goldstein, M., 1973, Mol. Pharmacol. 9: 117.
Johnston, J. P., 1968, Biochem. Pharmacol. 17: 1285.
Joyce, D., 1962, Brit. J. Pharmacol. 18: 370.
Kapeller, K., and Major, D., 1967, Proc. Roy. Soc. London Ser B 167: 282.
Katz, R. I., Goodwin, J. S., and Kopin, I. J., 1969, Life Sci. (Part 11)8:561.
Katz, R. I., and Jacobson, A. E., 1972, Mol. Pharmacol. 8: 594.
Kaufman, S. 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 53–60, Pergamon Press, Oxford.
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., and Attack, C. (1972) J. Pharm. Pharmacol. 24: 744.
Kirshner, N., and Goodall, McC. 1956, Federation Proc. 15: 110.
Kirshner, N., and Goodall, McC., 1957, Biochim. Biophys. Acta 24: 658.
Kitabchi, A. E., and Williams, R. H., 1969, Biochim. Biophys. Acta 178: 181.
Koelle, G. B., 1959, Pharmacol. Rev. 11: 381.
Kopin, I.J., 1964, Pharmacol. Rev. 16: 179.
Kopin, I. J., 1968, Ann. Rev. Pharmacol. 8: 377.
Kopin, I. J., and Gordon, E. K., 1962, J. Pharmacol. Exptl. Therap. 138: 351.
Kopin, I. J., and Gordon, E. K., 1963a, J. Pharmacol. Exptl. Therap. 140: 207.
Kopin, I. J., Gordon, E. K., and Horst, W. D. 1965, Biochem. Pharmacol. 14: 753.
Kopin, I. J., Weise, V. K., and Sedvall, G. C. 1969, J. Pharmacol. Exptl. Therap. 170: 246.
Koslow, S. H., Cattabeni, F., and Costa, E., 1972, Science 176: 177.
Krakoff, L. R., and Axelrod, J., 1967, Biochem. Pharmacol. 16: 1384.
Kuczenski, R. T., and Mandell, A. J., 1972, J. Biol. Chem. 247: 3114.
Kuehl, F. A., Jr., Ormond, R. E., and Vandenheuvel, W. J. A., 1966, Nature 211: 606.
Kukovetz, W. R., Hess, M. E., Shanfield, J., and Haugaard, N., 1959, J. Pharmacol. Exptl. Therap. 127: 122.
Laduron, P., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 121–128, Pergamon Press, Oxford.
Lancaster, G. A., and Sourkes, T. L., 1972, Can. J. Biochem. 50: 791.
Lapetina, E. G., Soto, E. F., and De Robertis, E., 1968, J. Neurochem. 15: 437.
Laverty, R., Michaelson, I. A., Sharman, D. F., and Whittaker, V. P., 1963, Brit. J. Pharmacol. Chemother. 21: 482.
Leeper, L. C., and Udenfriend, S., 1956, Federation Proc. 15: 298.
Lever, J. D., and Esterhuizen, A. C., 1961, Nature 192: 566.
Levin, E. Y., and Kaufman, S., 1961, J. Biol. Chem. 236: 2043.
Lindvall, O., Björklund, A., and Falck, B., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 683–687, Pergamon Press, Oxford.
Loewi, O. 1921, Pf iiiegers Arch. Ges. Physiol. 189: 239.
Lovenberg, W., Weissbach, H., and Udenfriend, S., 1962, J. Biol. Chem. 237: 89.
Mandel, P., Ciesielski-Treska, J., Hermetet, J. C., Hertz, L., Nissen, C., Tholey, G. and Warter, F., 1974, In: Central Nervous System. Studies on Metabolic Regulation and Function (E. Genazzani and H. Herken, eds.), pp. 223–230, Springer-Verlag, Berlin.
Marks, B. H., Samorajski, T., and Webster, E. J., 1962, J. Pharmacol. Exptl. Therap. 138: 376.
Masri, M. S., Booth, A. N., and Deeds, F., 1962, Biochim. Biophys. Acta 65: 495.
Masri, M. S., Robbins, D. J., Emerson, O. H., and Deeds, F., 1964, Nature 202: 878.
Masuoka, D. T., Clark, W. G., and Schott, H. F., 1961, Rev. Canad. Biol. 20: 1.
Masuoka, D. T., Schott, H. F., Akawie, R. I., and Clark, W. G., 1956, Proc. Soc. Exptl. Biol. Med. 93: 5.
Masuoka, D. T., Schott, H. F., and Petriello, L., 1963, J. Pharmacol. Exptl. Therap. 139: 73.
Mathieu, P., and Revol, L., 1970, Bull. Soc. Chim. Biol. 52: 1039.
McGeer, E. G., and McGeer, P. L. 1962, Can. J. Biochem. Physiol. 40: 1141.
Meek, J. L., and Foldes, A., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 167–171, Pergamon Press, Oxford.
Meek, J. L., and Neff, N. H., 1973, J. Neurochem. 21: 1.
Mena, I., Crout, J., and Cotzias, G. C., 1971, J. Am. Med. Assoc. 218: 1829–1830.
Miras-Portugal, M. T., Aunis, D., and Mandel, P. 1975a, Biochimie (in press).
Mirkin, B. L., and Bonnycastle, D. D., 1954, Am. J. Physiol. 178: 529.
Molinoff, P. B., and Axelrod, J., 1971, Ann. Rev. Biochem. 40: 465.
Montagu, K. A. 1957, Nature 180: 244.
Montagu, K. A., 1963, Biochem. J. 86: 9.
Moore, R. Y. 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 767–769, Pergamon Press, Oxford.
Mueller, R. A., Thoenen, H., and Axelrod, J., 1969a, J. Pharmacol. Exptl. Therap. 169: 74.
Mueller, R. A., Thoenen, H., and Axelrod, J., 1969b, Mol. Pharmacol. 5: 463.
Musacchio, J. M., d’Angelo, G. L., and McQueen, C. A., 1971a, Proc. Natl. Acad. Sci. (U.S.) 68: 2087.
Musacchio, J. M., and Craviso, G. L., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 47–52, Pergamon Press, Oxford.
Musacchio, J. M., McQueen, C. A., and Craviso, G. L., 1973, In: New Concepts in Neurotransmitter Regulation (A. J. Mandell, ed.), pp. 69–88, Plenum Press, New York.
Nagatsu, T., Kato, T., Kuzuya, H., Umezawa, H. and Takenchi, T. 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 83–86, Pergamon Press, Oxford.
Nagatsu, T., Levitt, M., and Udenfriend, S., 1964, Biochem. Biophys. Res. Commun. 14: 543.
Nagatsu, T., Mizutani, K., Nagatsu, I., Matsuura, S., and Sugimoto, T. 1972, Biochem. Pharmacol. 21: 1945.
Nakashima, Y., Suzue, R., Sanada, H., and Kowada, S., 1972, Arch. Biochem. Biophys. 152: 515.
Neff, N. H., Yang, H. Y. T., and Goridis, C. (1973) In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 133–138, Pergamon Press, Oxford.
Neri, R., Hayano, M., Stone, D., Dorfman, R. I., and Elmanjian, F., 1956, Arch. Biochem. Biophys. 60: 297.
Nickerson, M., Berghout, J., and Hammerström, R. N., 1950, Am. J. Physiol. 160: 479.
Nikodijevik B., Daly, J., and Creveling, C. R., 1969, Biochem. Pharmacol. 18: 1577.
Nobin, A., and Björklund, A., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 677–681, Pergamon Press, Oxford.
Palade, G. E., and Palay, S. L. 1954, Anat. Rec. 188, 335.
Pellerin, J., and d’Iorio, A., 1957, Can. J. Biochem. Physiol. 35: 151.
Perry, T. L., Hansen, S., and Macintyre, L., 1964, Nature 202: 519.
Petrak, B., Fetzer, V., and Altiere, R. 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 97–100, Pergamon Press, Oxford.
Pletscher, A., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 27–37, Pergamon Press, Oxford.
Pletscher, A., Brossi, A., and Gey, K. F., 1962, Intern. Rev. Neurobiol. 4: 275.
Pletscher, A., Gey, K. F., and Burkard, W. P., 1966, In: Handbook of Experimental Pharmacology Vol. 19, (O. Eichler and A. Farah, eds.), pp. 593–735, Springer-Verlag, Berlin.
Pohorecky, L. A., Zigmond, M., Karten, H., and Wurtman, R. J., 1969, J. Pharmacol. Exptl. Therap. 165: 190.
Porter, C. C., 1971, Federation Proc. 30: 871.
Potter, T. L., and Axelrod, J., 1963, J. Pharmacol. Exptl. Therap. 142: 291.
Raab, W., and Gigee, W., 1953, Arch. Exptl. Pathol. Pharmak. 219: 248.
Raab, W., and Gigee, W., 1955, Circulation Res. 3: 553.
Raab, W., and Humphreys, R. J., 1947, J. Pharmacol. Exptl. Therap. 89: 64.
Raskin, N. H., and Sokoloff, L., 1970, J. Neurochem. 17: 1677.
Rose11, S., Kopin, I. J., and Axelrod, J., 1963, Am. J. Physiol. 205: 317.
Ross, S. B., and Haljasmaa, O., 1964, Acta Pharmacol. Toxicol. Scand. 21: 215.
Ross, S. B., and Renyi, A. L., 1964, Acta Pharmacol. Toxicol. Scand. 21: 226.
Rutledge, C. O., and Jonason, J., 1967, J. Pharmacol. Exptl. Therap. 157: 493.
Saelens, J. K., Schoen, M. S., and Kovacsics, G. B., 1967, Biochem. Pharmacol. 16: 1043.
Samorajski, T., and Marks, B. H. 1962, J. Histochem. Cytochem. 10: 392.
Sano, I., Gamo T., Kakimoto, Y., Taniguchi, K., Takesada, M., and Nishinuma, K., 1959, Biochim. Biophys. Acta 32: 586.
Schanberg, S. M., Breese, G. R., Schildkraut, J. J., Gordon, E. K., and Kopin, I., 1968, Biochem. Pharmacol. 17: 2006.
Schayer, R. W., 1951, J. Biol. Chem. 189: 301.
Seiler, N., and Wiechmann, M. 1967, J. Chromatog. 28: 351.
Sen, N. P., and McGeer, P. L., 1964, Biochem. Biophys. Res. Commun. 14: 227.
Senoh, S., Daly, J., Axelrod, J., and Witkop, B., 1959, J. Am. Chem. Soc. 81: 6240.
Shiman, R., Akino, M., and Kaufman, S. 1971, J. Biol. Chem. 246: 1330.
Shiman, R., and Kaufman, S., 1970, Methods in Enzymology Vol. 17A, pp. 609–615.
Shimizu, H., and Daly, J. W., 1972, European J. Pharmacol. 17: 240.
Shore, P. A., 1972, Ann. Rev. Pharmacol. 12: 209.
Silberstein, S. D., Shein, H. M., and Ber, K. R., 1972, Brain Res. 41: 245.
Sims, K. L., and Bloom, F. E., 1973, Brain Res. 49: 165.
Sims, K. L., Davis, G. A., and Bloom, F. E., 1973, J. Neurochem. 20: 449.
Sjoerdsma, A., 1961, Circulation Res. 9: 734.
Sjoerdsma, A., 1966, Pharmacol. Rev. 18: 673.
Sjöstrand, F. S., 1954, Z. Wiss. Mikroskopie. 62: 65.
Smith, A. D., 1968, In: A Symposium on the Interaction of Drugs and Subcellular Components in Animal Cells (P. N. Campbell, ed.), pp. 239–292, J. & A. Churchill, London.
Smith, D. S., Järlfors, U., and Beraneck, R., 1970, J. Cell Biol. 46: 199.
Sourkes, T. L., 1954, Arch. Biochem. Biophys. 51: 444.
Spector, S., Gordon, R., Sjoerdsma, A., and Udenfriend, S., 1967, Mol. Pharmacol. 3: 549.
Spector, S., Sjoerdsma, A., and Udenfriend, S., 1965, J. Pharmacol. Exptl. Therap. 147: 86.
Squires, R. F. 1972, In: Advances in Biochemical Psychopharmacology Vol. 5, (E. Costa, ed.), pp. 355–370, Raven Press, New York.
Stabenan, J. R., Creveling, C. R., and Daly, J., 1970, Am. J. Psychiat. 127: 611.
Stinson, R. H., 1961, Can. J. Biochem. Physiol. 39: 309.
Sugden, R. F., and Eccleston, D. J., 1971, J. Neurochem. 18: 2461.
Sulser, F., and Sanders-Bush, E., 1971, Ann. Rev. Pharmacol. 11: 209.
Tabakoff, B., and Erwin, V. G., 1970, J. Biol. Chem. 245: 3263.
Taylor, K. M., and Laverty, R., 1969, J. Neurochem. 16: 1367.
Thoenen, H., Kettler, R., Burkard, W., and Saner, A., 1971, NaunynSchmiedebergs Arch. Exptl. Pathol. Pharmak. 270: 146.
Thomas, J. A., Van Orden, L. S., III, Redick, J. A., and Kopin, I. J., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 79–81, Pergamon Press, Oxford.
Thureson-Klein, A., Klein, R. L., Lagercrantz, H., and Stjärne, L., 1970, Experientia 26: 994
Tranzer, J. P., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 453–458, Pergamon Press, Oxford.
Tranzer, J. P., and Thoenen, H., 1967, Experientia 23: 123.
Tranzer, J. P., and Thoenen, H., 1968, Experientia 24: 484.
Turner, A. J., and Tipton, K. F. 1972, European J. Biochem. 30: 361.
Udenfriend, S., 1962Fluorescence Assay in Biology and Medicine Academic Press, New York.
Udenfriend, S., and Wyngaarden, J. B., 1956, Biochim. Biophys. Acta 20: 48.
Udenfriend, S., and Zaltzman-Nirenberg, P., 1963, Science 142: 394.
Udenfriend, S., Creveling, C. R., Ozaki, M., Daly, J. W., and Witkop, B., 1959, Arch. Biochem. Biophys. 84: 249.
Udenfriend, S., Zaltzman-Nirenberg, P., and Nagatsu, T., 1965, Biochem. Pharmacol. 14: 837.
Ungerstedt, U., 1968, European J. Pharmacol. 5: 107.
Ungerstedt, U., and Ljungberg, T., 1973, In: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), pp. 689–693, Pergamon Press, Oxford.
Viveros, O. H., Arqueros, L., and Kirshner, N., 1968, Life Sci. 7: 609.
Wagner, A. F., Cirillo, V. J., Meisinger, M. A. P., Ormond, R. E., Kuehl, F., Jr., and Brink, N. G., 1966, Nature 211: 604.
Weil-Malherbe, H., 1961, In: Methods in Medical Research Vol. IX (Quastel, ed.), pp. 130–146.
Weil-Malherbe, H., and Bone, A. D., 1952, Biochem. J. 51: 311.
Weiner, N. 1970, Ann. Rev. Pharmacol. 10: 273.
Weiner, N., and Selvaratnam, I., 1968, J. Pharmacol. Exptl. Therap. 161: 21.
Whitby, L. G., Axelrod, J., and Weil-Malherbe, H., 1961, J. Pharmacol. Exptl. Therap. 132: 193.
Whitsett, T. L., McKinney, A. S., and Goldberg, L. I., 1970, Clin. Res. 18: 28.
Whittaker, V. P., 1966, Ann. N.Y. Acad. Sci. 137: 982.
Wolfe, D. E., Potter, L. T., Richardson, K. C., and Axelrod, J., 1962 Science 138: 440.
Woods, R. I., 1970, Proc. Roy. Soc. London Ser B 176: 63.
Yahr, M. D., Duvoisin, R. C., Shear, M. J., Barrett, R. E., and Hoeln, M. M., 1969, Arch. Neurol. 21: 343.
Youdim, M. B. H., 1972 Monoamine oxidases: New vistas in: Advances in Biochemical Psychopharmacology, Vol. 5(E. Costa and M. Sandler, eds.), pp. 67–77,Raven Press, New York.
Zeller, E. A., and Barsky, J., 1952, Proc. Soc. Exptl. Biol. 81: 459.
Zeller, E. A., and Hsu, M., 1973, In: Frontiers in Catecholamine Research, (E. Usdin and S. Snyder, eds.), pp. 153–155, Pergamon Press, Oxford.
Zeller, E. A., Barsky, J., Berman, E. R., and Fouts, J. R., 1952, J. Lab. Clin. Med. 40: 965.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Mandel, P., Mack, G., Goridis, C. (1975). Function of the Central Catecholaminergic Neuron: Synthesis, Release, and Inactivation of Transmitter. In: Friedhoff, A.J. (eds) Catecholamines and Behavior · 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3135-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3135-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3137-7
Online ISBN: 978-1-4684-3135-3
eBook Packages: Springer Book Archive